Japanese clinical practice guideline for diabetes 2019

E Araki, A Goto, T Kondo, M Noda, H Noto… - Diabetology …, 2020 - Springer
The current guideline represents the 6th edition of the “Japanese Clinical Practice Guideline
for Diabetes” which has been revised every three years since its first appearance in 2004 to …

The Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2019)

S Umemura, H Arima, S Arima, K Asayama… - Hypertension …, 2019 - nature.com
The Japanese Society of Hypertension (JSH) revised the Guidelines for the Management of
Hypertension 2014 (JSH 2014), and published the JSH 2019. In the development of the JSH …

[PDF][PDF] 中国2 型糖尿病防治指南(2013 年版)

翁建平 - 中华糖尿病杂志, 2014 - meditool.cn
随着经济高速发展和工业化进程的加速, 生活方式的改变和老龄化进程的加速,
使我国糖尿病的患病率正呈快速上升的趋势, 成为继心脑血管疾病, 肿瘤之后另一个严重危害 …

[HTML][HTML] Glycemia reduction in type 2 diabetes—microvascular and cardiovascular outcomes

GRADE Study Research Group - New England Journal of …, 2022 - Mass Medical Soc
Background Data are lacking on the comparative effectiveness of commonly used glucose-
lowering medications, when added to metformin, with respect to microvascular and …

Epidemiology of diabetes mellitus and cardiovascular disease

D Glovaci, W Fan, ND Wong - Current cardiology reports, 2019 - Springer
Abstract Purpose of Review Diabetes mellitus (DM) has become a rising epidemic in the last
century, more pressing in the last few decades with the exponential rise of obesity, and has …

Standards of medical care for type 2 diabetes in China 2019

W Jia, J Weng, D Zhu, L Ji, J Lu, Z Zhou… - Diabetes/metabolism …, 2019 - Wiley Online Library
The prevalence of diabetes in China has increased rapidly from 0.67% in 1980 to 10.4% in
2013, with the aging of the population and westernization of lifestyle. Since its foundation in …

Serum urate lowering with allopurinol and kidney function in type 1 diabetes

A Doria, AT Galecki, C Spino… - … England Journal of …, 2020 - Mass Medical Soc
Background Higher serum urate levels are associated with an increased risk of diabetic
kidney disease. Lowering of the serum urate level with allopurinol may slow the decrease in …

Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis

D Ettehad, CA Emdin, A Kiran, SG Anderson… - The Lancet, 2016 - thelancet.com
Background The benefits of blood pressure lowering treatment for prevention of
cardiovascular disease are well established. However, the extent to which these effects …

Blood pressure lowering in type 2 diabetes: a systematic review and meta-analysis

CA Emdin, K Rahimi, B Neal, T Callender, V Perkovic… - Jama, 2015 - jamanetwork.com
Importance Lowering blood pressure (BP) is widely used to reduce vascular risk in
individuals with diabetes. Objective To determine the associations between BP–lowering …

Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial

K Ueki, T Sasako, Y Okazaki, M Kato… - The lancet Diabetes & …, 2017 - thelancet.com
Background Limited evidence suggests that multifactorial interventions for control of
glucose, blood pressure, and lipids reduce macrovascular complications and mortality in …